Description
Seeking adults whose Multiple Myeloma has returned after treatment (Relapsed or Refractory) for a study of an investigational drug combination.
Overview
Participants in this study will be given the investigational drug combination (one as an injection and the other as a daily pill) over 28-day cycles.
What we're hoping for
We are studying the safety of an investigational drug combination for adults with Multiple Myeloma that has returned after treatment (Relapsed or Refractory). One of the drugs is FDA approved and the other has not yet been approved.
Additional Information
ClinicalTrials.gov Identifier: NCT06215118